ANTISENSE THERAPEUTICS LIMITED (ASX:ANP)
Company
Key Dates
Announcements
ANP - Commencement of Phase IIa Multiple Sclerosis Trial - Mr Mark Diamond, CEOThu, 29 Jun 2006 2:00pm
Executives & Directors
Chairman
Managing Director, CEO
Non Exec. Director
Non Exec. Director
Non Exec. Director
CFO
Investor Relations
Secretary
Please contact the ASX to change these details
Company Podcasts
Interim Results
Wed, 22 Feb 2012
Annual General Meeting
Tue, 8 Nov 2011
Full Year Results
Thu, 11 Aug 2011
Interim Results
Thu, 17 Feb 2011
Annual General Meeting
Tue, 9 Nov 2010
Quarterly Sales Date
Wed, 27 Oct 2010
Annual General Meeting
Fri, 13 Nov 2009 12:00pm
Full Year Results
Wed, 19 Aug 2009
Interim Results
Thu, 5 Feb 2009
Annual General Meeting
Fri, 31 Oct 2008 10:00am
| Amended 708A Notice | Wed, 9 May 2012 |
| Funding for ATL1103 Phase II Trial and Pipeline Activities | Mon, 7 May 2012 |
| Appendix 3B and 708A Notice | Mon, 7 May 2012 |
| Change of Director`s Interest Notice (RM) | Mon, 7 May 2012 |
| Change of Director`s Interest Notice (MD) | Mon, 7 May 2012 |
| Change of Director`s Interest Notice (CB) | Mon, 7 May 2012 |
| Completion of Capital Raising | Fri, 4 May 2012 |
| Change of Director`s Interest Notice (CB, MD, RM) | Thu, 3 May 2012 |
| Meeting Results - Shareholders Endorse Capital Raising | Mon, 30 Apr 2012 |
| Appendix 3B | Fri, 27 Apr 2012 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. BRR Media does not claim any association with any company listed on this site.
